Tvardi Therapeutics, Inc.

US$0.96As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:TVRDHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE (126.19%)
Biotechnology
Beta (5Y) —
PE TTM —
TSR TTM (79.40%)
Mkt cap US$12.78M
ROIC (81.53%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.23
27.91%
(60.20%)
Hold 0|12|3|12|9
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.02
0.02
0.02
0.03
15.60%
18.49%
15.17%
17.27%
Revenue$M
1.609
1.573
1.536
1.499
7.60%
3.89%
(3.55%)
(7.69%)
Peers (US$12.78M)
Cap (US$)
PE
12.87M
—
12.79M
—
Capital
TTM
5Y
10Y
Leveragex
0.830
(0.011)
(0.011)
EBIT/Intx
0.166
1.213
1.213
Own earn%
42.81
(28.73)
(33.47)
Sh yield%
31.30
35.92
33.57
Owners
Insiders/Inst%
1.93
34.69
Short interest%
0.66
SBC / revenue%
2.89
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
10
Op margin range%
9–15
$1 testx
0.2
Incr. ROIC%
47